Home » Newsletters » BioWorld Science

BioWorld Science

March 19, 2020

View Archived Issues

NEFAs nefarious role in pancreatitis

Enrollment begins in phase I study of AmnioBoost for treatment of COVID-19

Opioid analgesic CYX-6 displays antinociception without constipation, respiratory depression

Cellenkos seeks to advance CK-0802 for CoV-ARDS

CanSino receives clearance in China for phase I trials with Ad5-nCoV candidate vaccine for COVID-19

SELLAS presents positive data from phase II VADIS study of nelipepimut-S

Mateon to develop OT-101 against COVID-19

Positive final data from phase Ib study of Allocetra-OTS in severe sepsis

Pneumagen announces new program to target COVID-19 infections

Armata awarded up to USD 5 million from CFF for the development AP-PA02

The University of Washington discloses new ERN1/ERN2 inhibitors

Clinical data published on vincristine and irinotecan in children with Wilms tumor

IDO-1 inhibitors discovered at Bristol-Myers Squibb

Testing, testing: first repurposing trial for COVID-19 falls flat

Phase II data reported for preoperative letrozole in DCIS

Zolgensma approved in Japan for SMA

Global phase III trial to evaluate Actemra for severe COVID-19 pneumonia

Researchers identify novel biomarkers in Crohn's disease

Pfizer reports phase III data on 20-valent pneumococcal conjugate vaccine in vaccine-naive adults

Cellphire cleared to begin phase II study of Thrombosomes in bleeding patients with thrombocytopenia

Northwestern University synthesizes new glucosylceramidase modulators

Xenon Pharmaceuticals patents Nav1.6 channel blockers

New antitubercular compounds identified at Monash University

Identification and optimization of isoxazole amides as potent and selective SMYD3 inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...